Synthesis and biological evaluation of PEG-tirofiban conjugates.

Fiche publication


Date publication

mars 2008

Auteurs

Membres identifiés du Cancéropôle Est :
Dr DESAUBRY Laurent


Tous les auteurs :
Desaubry L, Riche S, Laeuffer P, Cazenave JP

Résumé

We have conjugated tirofiban, an antagonist of the GPIIb/IIIa integrin receptor, to PEG, and shown that these polymers effectively inhibit platelet aggregation. This inhibition decreased with the size of the polymer. Our goal was to develop new cryoprotective agents to store frozen platelets. Surprisingly, tirofiban-conjugated PEG did not exhibit any protection.

Référence

Bioorg Med Chem Lett. 2008 Mar 15;18(6):2028-31